KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Merck (MRK) Operating Expenses (2016 - 2026)

Merck has reported Operating Expenses over the past 18 years, most recently at $19.8 billion for Q1 2026.

  • Quarterly Operating Expenses rose 105.9% to $19.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $54.1 billion through Mar 2026, up 23.74% year-over-year, with the annual reading at $43.9 billion for FY2025, 0.65% down from the prior year.
  • Operating Expenses was $19.8 billion for Q1 2026 at Merck, up from $13.0 billion in the prior quarter.
  • Over five years, Operating Expenses peaked at $20.4 billion in Q2 2023 and troughed at $9.6 billion in Q1 2025.
  • The 5-year median for Operating Expenses is $10.8 billion (2023), against an average of $12.3 billion.
  • Year-over-year, Operating Expenses tumbled 50.39% in 2024 and then skyrocketed 105.9% in 2026.
  • A 5-year view of Operating Expenses shows it stood at $10.3 billion in 2022, then skyrocketed by 61.64% to $16.7 billion in 2023, then tumbled by 31.31% to $11.5 billion in 2024, then increased by 13.32% to $13.0 billion in 2025, then skyrocketed by 52.7% to $19.8 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Operating Expenses are $19.8 billion (Q1 2026), $13.0 billion (Q4 2025), and $10.5 billion (Q3 2025).